[The clinico-immunological and allergological characteristics of aspirin-induced asthma].
Markov. A E AE; Kozachuk. I A IA
Key Findings
- 66 patients with aspirin‑induced asthma were evaluated for clinical and immunological traits
- Authors recommend thymic preparations such as thymalin and T‑activin for managing the condition
- Mild aspirin‑induced asthma may be treated with aspirin desensitization
Practical Outcomes
- Thymalin is suggested as a supportive supplement for aspirin‑induced asthma, but the study provides no dosage or strong efficacy data. Biohackers interested in respiratory health might consider it as an adjunct, but should prioritize proven asthma therapies and consult a healthcare professional before adding thymalin.
Summary
A study of 66 people with aspirin‑triggered asthma looked at their symptoms and immune status and suggested using thymic extracts like thymalin, along with other supplements, as part of treatment. It also notes that mild cases can try aspirin desensitization.
Abstract
A study is presented of 66 patients with aspirin bronchial asthma (BA) and the clinical, pathogenetical, immunological and allergological state of these patients is described. For the treatment of patients with aspirin asthma the authors recommend to use zaditen, intal, thymic preparations (thymalin, T-activin), quercetin. In mild forms of bronchial asthma aspirin desensitization is possible.
Study Information
pubmed
1991